180 related articles for article (PubMed ID: 34249371)
1. The NICE Evidence Standards Framework for digital health and care technologies - Developing and maintaining an innovative evidence framework with global impact.
Unsworth H; Dillon B; Collinson L; Powell H; Salmon M; Oladapo T; Ayiku L; Shield G; Holden J; Patel N; Campbell M; Greaves F; Joshi I; Powell J; Tonnel A
Digit Health; 2021; 7():20552076211018617. PubMed ID: 34249371
[TBL] [Abstract][Full Text] [Related]
2. Application of the National Institute for Health and Care Excellence Evidence Standards Framework for Digital Health Technologies in Assessing Mobile-Delivered Technologies for the Self-Management of Type 2 Diabetes Mellitus: Scoping Review.
Forsyth JR; Chase H; Roberts NW; Armitage LC; Farmer AJ
JMIR Diabetes; 2021 Feb; 6(1):e23687. PubMed ID: 33591278
[TBL] [Abstract][Full Text] [Related]
3. Medical Mobile App Classification Using the National Institute for Health and Care Excellence Evidence Standards Framework for Digital Health Technologies: Interrater Reliability Study.
Nwe K; Larsen ME; Nelissen N; Wong DC
J Med Internet Res; 2020 Jun; 22(6):e17457. PubMed ID: 32501271
[TBL] [Abstract][Full Text] [Related]
4. Mobile Safety Alarms Based on GPS Technology in the Care of Older Adults: Systematic Review of Evidence Based on a General Evidence Framework for Digital Health Technologies.
Ehn M; Richardson MX; Landerdahl Stridsberg S; Redekop K; Wamala-Andersson S
J Med Internet Res; 2021 Oct; 23(10):e27267. PubMed ID: 34633291
[TBL] [Abstract][Full Text] [Related]
5. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development.
Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J
Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626
[TBL] [Abstract][Full Text] [Related]
6. Institute for Clinical and Economic Review - Peterson Health Technology Institute value assessment framework for digital health technologies.
Pearson SD; Singh P; Beaudoin F; Campbell J; Schapiro L; Emond SK; Pearson C
J Comp Eff Res; 2023 Dec; 12(12):e230154. PubMed ID: 37965898
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions.
Main C; Haig M; Chavez D; Kanavos P
Med Decis Making; 2024 Jan; 44(1):28-41. PubMed ID: 37882333
[TBL] [Abstract][Full Text] [Related]
8. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
9. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks.
Yan K; Balijepalli C; Druyts E
Front Digit Health; 2021; 3():667016. PubMed ID: 34713140
[TBL] [Abstract][Full Text] [Related]
12. Engaging with stakeholders to inform the development of a decision-support tool for the NHS health check programme: qualitative study.
Hyseni L; Guzman-Castillo M; Kypridemos C; Collins B; Schwaller E; Capewell S; Boland A; Dickson R; O'Flaherty M; Gallacher K; Hale P; Lloyd-Williams F
BMC Health Serv Res; 2020 May; 20(1):394. PubMed ID: 32393313
[TBL] [Abstract][Full Text] [Related]
13. Views of Directors of Public Health about NICE Appraisal Guidance: results of a postal survey. National Institute for Clinical Excellence.
Davies E; Littlejohns P
J Public Health Med; 2002 Dec; 24(4):319-25. PubMed ID: 12546211
[TBL] [Abstract][Full Text] [Related]
14. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
[TBL] [Abstract][Full Text] [Related]
15. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.
Lord J; Willis S; Eatock J; Tappenden P; Trapero-Bertran M; Miners A; Crossan C; Westby M; Anagnostou A; Taylor S; Mavranezouli I; Wonderling D; Alderson P; Ruiz F
Health Technol Assess; 2013 Dec; 17(58):v-vi, 1-192. PubMed ID: 24325843
[TBL] [Abstract][Full Text] [Related]
16. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
Williams I; McIver S; Moore D; Bryan S
Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
[TBL] [Abstract][Full Text] [Related]
17. Innovation as a value in healthcare priority-setting: the UK experience.
Charlton V; Rid A
Soc Justice Res; 2019; 32(2):208-238. PubMed ID: 31281204
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
